WallStreetZenWallStreetZen

NASDAQ: AKBA
Akebia Therapeutics Inc Stock Ownership - Who owns Akebia Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Akebia Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michel DahanSVP Chief Operating Officer2024-05-1334,840$1.26
$43.90kSell
Nicole R. HadasSVP Chief Legal Officer2024-05-1312,016$1.26
$15.14kSell
Nicole R. HadasSVP Chief Legal Officer2024-02-295,974$1.58
$9.44kSell
Michel DahanSVP Chief Operating Officer2024-02-298,661$1.58
$13.68kSell
Steven Keith BurkeSVP Chief Medical Officer2024-02-297,169$1.58
$11.33kSell
John P. ButlerCEO and President2024-02-2946,570$1.58
$73.58kSell
Michel DahanSVP Chief Operating Officer2024-02-2710,744$1.52
$16.33kSell
Steven Keith BurkeSVP Chief Medical Officer2024-02-278,367$1.52
$12.72kSell
John P. ButlerCEO and President2024-02-2737,733$1.52
$57.35kSell
Nicole R. HadasSVP Chief Legal Officer2024-02-277,411$1.52
$11.26kSell

1 of 2

AKBA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AKBA insiders and whales buy or sell their stock.

AKBA Shareholders

What type of owners hold Akebia Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc 16.97%15,197,207$30.70MInstitution
Vanguard Group Inc4.62%10,070,298$20.34MInstitution
Alerce Investment Management LP2.63%5,747,906$11.61MInstitution
Muneer A. Satter2.31%5,039,602$10.18MInsider
Geode Capital Management LLC2.18%4,754,464$9.60MInstitution
Renaissance Technologies LLC1.70%3,717,800$7.51MInstitution
State Street Corp1.57%3,430,527$6.93MInstitution
Novartis Bioventures Ltd1.56%3,405,764$6.88MInsider
John P. Butler1.35%2,942,080$5.94MInsider
Jacobs Levy Equity Management Inc0.93%2,034,169$4.11MInstitution

1 of 3

AKBA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AKBA27.22%8.73%Net Selling
AURA73.80%17.41%Net SellingNet Selling
RIGL30.01%69.99%Net Selling
ZBIO59.09%4.58%Net BuyingNet Buying
ALLO67.92%32.08%Net BuyingNet Selling
View Top Biotech Stocks

Akebia Therapeutics Stock Ownership FAQ

Who owns Akebia Therapeutics?

Akebia Therapeutics (NASDAQ: AKBA) is owned by 27.22% institutional shareholders, 8.73% Akebia Therapeutics insiders, and 64.05% retail investors. Muneer A. Satter is the largest individual Akebia Therapeutics shareholder, owning 5.04M shares representing 2.31% of the company. Muneer A. Satter's Akebia Therapeutics shares are currently valued at $10.33M.

If you're new to stock investing, here's how to buy Akebia Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.